Euglena Species: Bioactive Compounds and their Varied Applications

Area of Science:

• Microbiology
• Biotechnology
• Pharmacology

Background:

• Euglena, a genus of over 300 unicellular freshwater flagellates, is recognized for its rich bioactive compound profile.
• These compounds have potential applications in food supplements, pharmaceuticals, and biofuels.

Purpose of the Study:

• To review updated information on the pharmacological and therapeutic properties of molecules from Euglena species.
• To discuss the industrial implications of these compounds.

Main Methods:

• A comprehensive bibliographic search of scientific literature was conducted.
• Databases were searched using various search engines for studies published up to March 2020.

Main Results:

• Euglena species produce numerous antioxidant molecules (e.g., beta-carotene, L-ascorbic acid), unsaturated fatty acids, and phytotoxins.
• These compounds are valuable for pharmaceutical, cosmetic, and nutraceutical manufacturing.
• Euglena is a source of antimicrobial, anticancer, and immunomodulatory agents.

Conclusions:

• Euglena exhibits significant therapeutic potential, supported by existing studies.
• Extensive research is required to fully ascertain efficacy for various conditions and conduct toxicity assessments.
• The biotechnological potential for industrial Euglena production remains largely underexplored.